Robin Hubler, MS

Pfizer
Pfizer Inc.

Disclosure(s): Pfizer, Inc.: Employee of Pfizer Inc., Stocks/Bonds (Private Company)

Poster(s):

• (P-604) Preliminary real-world Abrysvo vaccine effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related lower respiratory tract disease (LRTD) hospitalizations and emergency department (ED) visits—Kaiser Permanente of Southern California (KPSC), November 2023-April 2024
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT